2019 International Congress Archives - Page 31 of 217

Body Mass Gain in Parkinson’s Disease Following Deep Brain Stimulation: A Systematic Review

J. Steinhardt, T. Münte, S. Schmid, B. Wilms, N. Brüggemann (Lübeck, Germany)
Body Representation Impairments in Parkinson’s disease: A Preliminary Report

J. Cardona, C. Martinez, W. Correa, J. Grisales, C. Trujillo, F. Marmolejo-Ramos (Santiago de Cali, Colombia)
Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)
Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia

M. Field, A. Splevins, M. Schans, J. Langenberg, D. Noort, P. Picaut, K. Foster (Rijswijk, Netherlands)
Botulinum toxin for the management of dystonic scoliosis in children

D. Ferman, T. Sanger (Los Angeles, CA, USA)
Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity

L. Rocchi, A. Latorre, G. Paparella, E. Menozzi, L. Peppoloni, F. Valero-Cuevas, C. Cordivari, K. Bhatia, J. Rothwell (London, United Kingdom)
Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome

I. Bledsoe (San Francisco, CA, USA)
Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.

M. Velez, C. Cosentino, L. Torres (Lima, Peru)
BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson’s disease

W. Poewe, K. Kieburtz, F. Stocchi, S. Oren, T. Yardeni, L. Adar, O. Rosenfeld, C. Olanow (Innsbruck, Austria)
Braak model in Parkinson disease using MRI biomarkers

N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, M. Mongin, C. Ewenczyk, C. Gallea, F. Gargouri, E. Bardinet, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)